PL366993A1 - Sposób wytwarzania 10,11-dihydro-10-hydroksy-5H-dibenz [b,f] azepino-5-karboksyamidu i 10,11-dihydro-10-okso-5H-dibenz [b,f] azepino-5-karboksyamidu - Google Patents

Sposób wytwarzania 10,11-dihydro-10-hydroksy-5H-dibenz [b,f] azepino-5-karboksyamidu i 10,11-dihydro-10-okso-5H-dibenz [b,f] azepino-5-karboksyamidu

Info

Publication number: PL366993A1
Authority: PL; Poland
Prior art keywords: dibenz; azepine; carboxamide; dihydro; hydroxy
Prior art date: 2001-05-25

Application number

PL02366993A

Other languages

English (en)

Other versions

PL215305B1 (pl

Inventor

David Alexander Learmonth

Original Assignee

Portela & Ca, Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-25

Filing date

2002-05-22

Publication date

2005-02-07

2002-05-22 Application filed by Portela & Ca, Sa filed Critical Portela & Ca, Sa

2005-02-07 Publication of PL366993A1 publication Critical patent/PL366993A1/pl

2013-11-29 Publication of PL215305B1 publication Critical patent/PL215305B1/pl

Links

ZFXVFMBOFIEPII-UHFFFAOYSA-N 1h-azepine-4-carboxamide Chemical compound NC(=O)C1=CC=CNC=C1 ZFXVFMBOFIEPII-UHFFFAOYSA-N 0.000 title 2

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Epoxy Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Catalysts (AREA)

PL366993A 2001-05-25 2002-05-22 Sposoby wytwarzania 10,11-dihydro-10-hydroksy-5H-dibenzo [b,f] azepino-5-karboksyamidu, 10,11-dihydro-10-okso-5H-dibenzo [b,f] azepino-5-karboksyamidu, 1a,10b-dihydro-6H-dibenzo[b,f] oksireno [d] azepino-6-karboksyamidu oraz 10-acylowanej pochodnej 10,11-dihydro-10-hydroxy-5H-dibenzo [b,f] azepino-5-karboksyamidu PL215305B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0112812.3A GB0112812D0 (en)	2001-05-25	2001-05-25	Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom

Publications (2)

Publication Number	Publication Date
PL366993A1 true PL366993A1 (pl)	2005-02-07
PL215305B1 PL215305B1 (pl)	2013-11-29

Family

ID=9915332

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL366993A PL215305B1 (pl)	2001-05-25	2002-05-22	Sposoby wytwarzania 10,11-dihydro-10-hydroksy-5H-dibenzo [b,f] azepino-5-karboksyamidu, 10,11-dihydro-10-okso-5H-dibenzo [b,f] azepino-5-karboksyamidu, 1a,10b-dihydro-6H-dibenzo[b,f] oksireno [d] azepino-6-karboksyamidu oraz 10-acylowanej pochodnej 10,11-dihydro-10-hydroxy-5H-dibenzo [b,f] azepino-5-karboksyamidu

Country Status (23)

Country	Link
US (1)	US7241886B2 (pl)
EP (2)	EP1399424B8 (pl)
JP (3)	JP4323309B2 (pl)
KR (1)	KR100931916B1 (pl)
CN (2)	CN101172967A (pl)
AR (1)	AR035460A1 (pl)
AT (2)	ATE400560T1 (pl)
AU (2)	AU2002307863B8 (pl)
BR (1)	BR0210019A (pl)
CA (2)	CA2448094C (pl)
CY (3)	CY1108345T1 (pl)
CZ (1)	CZ303130B6 (pl)
DE (2)	DE60239842D1 (pl)
DK (2)	DK1399424T3 (pl)
ES (2)	ES2362688T3 (pl)
GB (1)	GB0112812D0 (pl)
HU (1)	HU230019B1 (pl)
LU (1)	LU91603I2 (pl)
MX (1)	MXPA03010793A (pl)
PL (1)	PL215305B1 (pl)
RU (2)	RU2311411C2 (pl)
SI (1)	SI1399424T1 (pl)
WO (1)	WO2002096881A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0303615D0 (en) *	2003-02-17	2003-03-19	Novartis Ag	Use of organic compounds
ITMI20042230A1 (it)	2004-11-19	2005-02-19	Farchemia Srl	Procedimento per la preparazione della 10,11-diidro-10 idrossi-5h-dibenz-b,f-azepin-5carbossiammide
ITMI20042291A1 (it) *	2004-11-26	2005-02-26	Farchema S R L	Procedimento per la preparazione della -s-piu-10,11-diidro-10-idrossi-5h-dibenz-b,f-azepin-5-carbossiammide
GB2422149A (en) *	2005-01-14	2006-07-19	Portela & Ca Sa	Process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide
US20060252745A1 (en)	2005-05-06	2006-11-09	Almeida Jose L D	Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0515690D0 (en)	2005-07-29	2005-09-07	Portela & Ca Sa	Asymmetric catalytic reduction
GB0517740D0 (en) *	2005-08-31	2005-10-12	Novartis Ag	Organic compounds
GB0700773D0 (en)	2007-01-15	2007-02-21	Portela & Ca Sa	Drug therapies
US8372431B2 (en) *	2007-10-26	2013-02-12	Bial-Portela & C.A., S.A.	Pharmaceutical composition comprising licarbazepine acetate
CA2769181C (en)	2009-07-27	2017-11-28	Bial-Portela & Ca., S.A.	Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia
US20150065704A1 (en)	2011-07-13	2015-03-05	Ketan Hirpara	Process for the preparation and purification of eslicarbazepine acetate and intermediates thereof
EP2900640A1 (en)	2012-09-26	2015-08-05	Ranbaxy Laboratories Limited	Process for the preparation of oxcarbazepine and its use as intermediate in the preparation of eslicarbazepine acetate
EP3350343B1 (en)	2015-09-16	2020-04-22	Petaomics, Inc.	Methods and compositions for genomic target enrichment and selective dna sequencing
US12492423B2 (en)	2015-09-16	2025-12-09	PetaOmics, Inc.	Methods and compositions for genomic target enrichment and selective DNA sequencing
CN111943347B (zh) *	2020-07-16	2022-08-30	同济大学	一种铜离子活化过氧乙酸去除废水中卡马西平的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5439390B2 (pl) *	1971-09-30	1979-11-27
BE789320A (fr) *	1971-09-30	1973-03-27	Takeda Chemical Industries Ltd	Derives de dibenzoxirenazepine
CH633271A5 (en)	1978-04-18	1982-11-30	Ciba Geigy Ag	Process for the rearrangement of 10,11-epoxy-10,11-dihydro-5H-dibenz[b,f]azepines to give 10-oxo-10,11-dihydro-5H-dibenz(b,f)azepines
CH642950A5 (en)	1979-10-30	1984-05-15	Ciba Geigy Ag	Process for the preparation of 10-oxo-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide
IT1272897B (it) *	1995-01-13	1997-07-01	I F C Iniziative Finanziaarie	Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
PT101732B (pt) *	1995-06-30	1997-12-31	Portela & Ca Sa	Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
PT101876B (pt) *	1996-05-27	1999-09-30	Portela & Ca Sa	Novos derivados de 10,11-di-hidro-10-oxo-5h-dibenzo(b,f)azepina-5-carboxamida
AT408224B (de) *	1999-03-15	2001-09-25	Dsm Fine Chem Austria Gmbh	Verfahren zur herstellung von oxcarbazepin

2001
- 2001-05-25 GB GBGB0112812.3A patent/GB0112812D0/en not_active Ceased
2002
- 2002-05-22 DE DE60239842T patent/DE60239842D1/de not_active Expired - Lifetime
- 2002-05-22 WO PCT/GB2002/002356 patent/WO2002096881A1/en not_active Ceased
- 2002-05-22 MX MXPA03010793A patent/MXPA03010793A/es active IP Right Grant
- 2002-05-22 ES ES08075527T patent/ES2362688T3/es not_active Expired - Lifetime
- 2002-05-22 CN CNA2007101939981A patent/CN101172967A/zh active Pending
- 2002-05-22 HU HU0400296A patent/HU230019B1/hu unknown
- 2002-05-22 AU AU2002307863A patent/AU2002307863B8/en not_active Ceased
- 2002-05-22 KR KR1020037015323A patent/KR100931916B1/ko not_active Expired - Fee Related
- 2002-05-22 ES ES02774050T patent/ES2305299T3/es not_active Expired - Lifetime
- 2002-05-22 SI SI200230717T patent/SI1399424T1/sl unknown
- 2002-05-22 EP EP02774050A patent/EP1399424B8/en not_active Expired - Lifetime
- 2002-05-22 BR BR0210019-3A patent/BR0210019A/pt active Search and Examination
- 2002-05-22 US US10/478,770 patent/US7241886B2/en not_active Expired - Lifetime
- 2002-05-22 AT AT02774050T patent/ATE400560T1/de active
- 2002-05-22 AT AT08075527T patent/ATE506351T1/de active
- 2002-05-22 DK DK02774050T patent/DK1399424T3/da active
- 2002-05-22 EP EP08075527A patent/EP1958938B1/en not_active Expired - Lifetime
- 2002-05-22 DK DK08075527.5T patent/DK1958938T3/da active
- 2002-05-22 PL PL366993A patent/PL215305B1/pl unknown
- 2002-05-22 RU RU2003137224/04A patent/RU2311411C2/ru active
- 2002-05-22 CA CA2448094A patent/CA2448094C/en not_active Expired - Lifetime
- 2002-05-22 CA CA2750876A patent/CA2750876C/en not_active Expired - Fee Related
- 2002-05-22 DE DE60227517T patent/DE60227517D1/de not_active Expired - Lifetime
- 2002-05-22 CN CN028105915A patent/CN1511141B/zh not_active Expired - Fee Related
- 2002-05-22 JP JP2003500061A patent/JP4323309B2/ja not_active Expired - Fee Related
- 2002-05-22 CZ CZ20033203A patent/CZ303130B6/cs not_active IP Right Cessation
- 2002-05-24 AR ARP020101958A patent/AR035460A1/es not_active Application Discontinuation
2007
- 2007-06-01 RU RU2007120532/04A patent/RU2449992C2/ru not_active IP Right Cessation
- 2007-10-04 AU AU2007221834A patent/AU2007221834B2/en not_active Ceased
2008
- 2008-08-05 JP JP2008201613A patent/JP2009057376A/ja active Pending
- 2008-09-17 CY CY20081100998T patent/CY1108345T1/el unknown
2009
- 2009-03-09 JP JP2009054515A patent/JP5280252B2/ja not_active Expired - Fee Related
- 2009-08-28 LU LU91603C patent/LU91603I2/fr unknown
- 2009-10-19 CY CY2009017C patent/CY2009017I2/el unknown
2011
- 2011-05-27 CY CY20111100515T patent/CY1111492T1/el unknown

Also Published As

Publication number	Publication date
EP1958938A3 (en)	2008-09-03
ES2305299T3 (es)	2008-11-01
PL215305B1 (pl)	2013-11-29
KR100931916B1 (ko)	2009-12-15
ES2362688T3 (es)	2011-07-11
DE60239842D1 (de)	2011-06-01
AU2007221834A1 (en)	2007-10-25
CY1108345T1 (el)	2012-01-25
HU230019B1 (hu)	2015-05-28
DK1958938T3 (da)	2011-07-25
US20040158060A1 (en)	2004-08-12
US7241886B2 (en)	2007-07-10
ATE400560T1 (de)	2008-07-15
CY2009017I1 (el)	2012-01-25
WO2002096881A1 (en)	2002-12-05
JP4323309B2 (ja)	2009-09-02
SI1399424T1 (sl)	2008-10-31
HUP0400296A2 (hu)	2004-08-30
AU2002307863B8 (en)	2007-10-18
EP1399424A1 (en)	2004-03-24
EP1958938A2 (en)	2008-08-20
MXPA03010793A (es)	2004-07-01
CA2448094A1 (en)	2002-12-05
EP1399424B8 (en)	2008-10-01
CY1111492T1 (el)	2015-08-05
RU2449992C2 (ru)	2012-05-10
CA2750876C (en)	2014-10-28
KR20040030626A (ko)	2004-04-09
EP1399424B1 (en)	2008-07-09
CN1511141A (zh)	2004-07-07
HUP0400296A3 (en)	2008-03-28
JP2004532263A (ja)	2004-10-21
CY2009017I2 (el)	2012-01-25
CA2448094C (en)	2011-11-01
RU2007120532A (ru)	2008-12-10
ATE506351T1 (de)	2011-05-15
DK1399424T3 (da)	2008-09-08
JP2009167194A (ja)	2009-07-30
CZ20033203A3 (cs)	2004-06-16
BR0210019A (pt)	2004-08-10
EP1958938B1 (en)	2011-04-20
JP5280252B2 (ja)	2013-09-04
CN1511141B (zh)	2011-06-08
AR035460A1 (es)	2004-05-26
WO2002096881A8 (en)	2003-02-27
AU2002307863B2 (en)	2007-09-27
CA2750876A1 (en)	2002-12-05
CN101172967A (zh)	2008-05-07
LU91603I2 (fr)	2009-10-28
RU2003137224A (ru)	2005-05-27
JP2009057376A (ja)	2009-03-19
DE60227517D1 (de)	2008-08-21
CZ303130B6 (cs)	2012-04-18
AU2007221834B2 (en)	2009-02-05
GB0112812D0 (en)	2001-07-18
RU2311411C2 (ru)	2007-11-27

Publication	Publication Date	Title
AU2002364528A8 (en)	2003-06-23	Bio-implant and method of making the same
AU2003233010A8 (en)	2003-12-19	Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
AU2002360670A8 (en)	2003-07-09	Method and related composition employing nanostructures
GB0220208D0 (en)	2002-10-09	Implant forming method
GB0218595D0 (en)	2002-09-18	Implant forming method
GB0128287D0 (en)	2002-01-16	Novel method and compounds
PL353633A1 (en)	2002-11-04	Method of obtaining derivatives of 4"-substituted-9-deoxy-9a-aza-9a-homoerythromycin
HUP9900163A3 (en)	2001-10-29	Process for the preparation of sterol-and stanol-esters, and use thereof
HUP0303811A3 (en)	2008-05-28	Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
HUP0400296A3 (en)	2008-03-28	Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5h-dibenz/b,f/azepine-5-carboxamide
IL159067A0 (en)	2004-05-12	METHODS FOR PREPARATION AND USE OF 1alpha,24 (S) -DIHYDROXYVITAMIN D2
EP1146136A4 (en)	2006-09-06	ORNAMENT AND METHOD FOR ITS MANUFACTURE
HUP0402475A3 (en)	2008-10-28	Process for the preparation of [1,4,5]-oxadiazepine derivatives
HUP0401577A3 (en)	2010-03-29	Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses
IL152795A0 (en)	2003-06-24	Method for the production of 2-coumarone and substituted 2-coumarones
AU2002337649A8 (en)	2009-07-30	Method of making fgf-12 and kgf-2
AU2795202A (en)	2002-06-18	Klainetin and derivatives thereof, method for their production and the use of the same
IL140739A0 (en)	2002-02-10	Glyceryl trinitrate-containing preparation, method for its production, and its use
PL347407A1 (en)	2001-11-19	Method of obtaining derivatives of 5,6,7,8-tetrahydronaphtalen-2-ole
PL349122A1 (en)	2003-02-24	Novel derivatives of 3-r-amino-4-substitute-1,2,4-triazolin-5-thione and method of obtaining them
PL349945A1 (en)	2003-04-07	Novel 3-r-4-substitute derivatives of deltha-1,2,4-triazolin-5-thione and method of obtaining them
PL346255A1 (en)	2002-09-09	Method of obtaining 5,6-dihydro-2-methyl-n-phenyl-1,4-oxathin-3-carboxamide
AU2002338891A1 (en)	2002-12-03	Method for the treatment of oligoamides and for the production of polyamides
AU2002315953A1 (en)	2003-01-29	Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses
PL347952A1 (en)	2001-12-03	Method of obtaining androst-4-ene 3,17-dione